Eli Lilly is still celebrating the FDA approval of its amyloid-directed Alzheimer's therapy Kisunla but has had less fortune with a candidate against tau, another well-established drug target for the ...
If you have type 2 diabetes, your regular A1C tests may be the most important measurement for evaluating the success of your diabetes management plan. That’s because your A1C is the strongest ...